Advances in the understanding of molecular biology and immunology (including virology) are occurring at a rapid pace and require dissemination of new findings in order to optimize clinical outcomes. Head and neck cancer is now considered 2 major diseases, one arising in smokers with/without the addition of alcohol abuse, the other resuling from infection with selected oncogenic human papilloma viruses. While their natural histories vary somewhat, HPV-associated disease generally more favorable than smoking-related disease, both groups have serious gaps in the achievement of satisfactory treatment outcomes. This session will address the rapidly-changing field of research and its application to the similarly-changing landscape of diagnostics and treatments for these malignancies.
Date:April 06, 2017
Time: 05:30 PM - 08:00 PM (PT)
Presenters:Thomas J. Gernon, MD & Erminia Massarelli, MD, PhD, MS
Who should attend:Medical Oncologists, Radiation Oncologists, Surgical Oncologists, Plastic Surgeons, Otolaryngologist, Oncologic Dentists and other allied healthcare professionals who treat patients with head and neck cancer.
CME credits:1.5 AMA/PRA Category 1 Credit™ The City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. City of Hope designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.TM
R.S.V.P.: Click Here To Register